Status:
WITHDRAWN
New Markers for Treatment Response to Radiotherapy in Prostate Cancer
Lead Sponsor:
University of Basel
Conditions:
Prostate Cancer
Eligibility:
MALE
18-85 years
Brief Summary
The actual follow-up of patients undergoing definite radiotherapy for prostate cancer includes regular measurements of prostate specific antigen (PSA). Successful radiotherapy is critically dependent ...
Detailed Description
Patients will be closely followed for 5 years (weeks 0, 2, 4, 6, and months 2, 3, 6, 9, 12, 18, 24, and then yearly). Each assessment includes PSA measurement, urine collection after prostatic massage...
Eligibility Criteria
Inclusion
- All patients undergoing radiotherapy of biopsy confirmed clinically localised adenocarcinoma of the prostate
Exclusion
- patients with inflammatory processes of the rectum
- patients with no rectum due to previous surgery
Key Trial Info
Start Date :
July 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06159998
Start Date
July 1 2009
End Date
July 1 2019
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Urology, University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031